An international, multicenter collaborative study of propranolol for hemangiomas is underway.
Topical beta-blockers also have been considered for hemangiomas. Preliminary data suggest they may produce a response in superficial, flat lesions. But topical beta-blockers also can have systemic side effects. Will they benefit infants with hemangiomas and be safe? "I don’t know. It's a good idea. We’ll see," he said.
Disclosures: Dr. Eichenfield said he has no pertinent conflicts of interest. A member of his division at the university is the primary investigator in a study of propranolol for hemangiomas.